Article 30 Dec 2016 Despite Granting A Request For Rehearing, The PTAB Maintained Its Finding That Teva's Copaxone Claims Were Unpatentable As Obvious, PTAB Litigation Blog United States IP
Article 30 Nov 2016 Invalidity Defenses Raised But Not Instituted During IPR Are Not Barred By Statutory Or Judicial Estoppel United States IP